Skip to content

Vor Biopharma VOR Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$219.59M-576%-$812.68M-2,849%-$1.57B-5,553%-$32.49M-5.5%
$28K-96.6%$23K-97.3%$2K-99.8%$2.1M+133%$825K-12.5%
$8.87M+359%$7.11M+316%$8.03M+255%$1.84M-34.0%$1.93M-37.3%
-$38.25M-23.1%-$22.8M+5.2%-$53.66M-130%-$35.18M-61.0%-$31.07M-2.0%
$48K-79.2%$314K+336%$244K+618%$152K+1,589%$231K+103%
-$263.24M-114,351%-$48.97M-$244K$646K-98.8%-$230K-101%
$74.87M+12,455%$307.8M+478%$21.55M+52,459%$175.07M-$606K-731%
-$226.61M-610%$236.02M+710%$140.53M+352%-$31.9M-335%
-$38.29M-22.4%-$23.12M+4.2%-$53.91M-131%-$35.34M-61.7%-$31.3M-2.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Vor Biopharma generate?
Vor Biopharma (VOR) generated -$149.9M in operating cash flow over the trailing twelve months.
What is Vor Biopharma's free cash flow?
After $758.0K of capital expenditures, Vor Biopharma's free cash flow was -$150.7M over the trailing twelve months, down 49.7% year over year.
Where does Vor Biopharma's cash flow data come from?
Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.